| P50 | author | Jonathan Rosand | Q23765874 |
| | Carl D. Langefeld | Q102208371 |
| | Mary E Comeau | Q107118925 |
| | Chelsea S. Kidwell | Q110243582 |
| P2093 | author name string | Daniel Woo | |
| | Padmini Sekar | |
| | Christiana Hall | |
| | Charles J Moomaw | |
| | Sharyl Martini | |
| | Fazeel M Siddiqui | |
| | Sonja Stutzman | |
| | Jennifer L Osborne | |
| P2860 | cites work | 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q28301815 |
| | The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study protocol | Q30410544 |
| | Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study | Q33183651 |
| | Issues of recruitment and maintaining high response rates in a longitudinal study of older hospital patients in England--pathways through care study. | Q33704663 |
| | Low total serum cholesterol and intracerebral hemorrhagic stroke: is the association confined to elderly men? The Kaiser Permanente Medical Care Program | Q34405483 |
| | Vascular recovery promoted by atorvastatin and simvastatin after experimental intracerebral hemorrhage: magnetic resonance imaging and histological study | Q35149252 |
| | Statin use following intracerebral hemorrhage: a decision analysis | Q35170660 |
| | Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association | Q35711431 |
| | Statins Protect the Blood Brain Barrier Acutely after Experimental Intracerebral Hemorrhage | Q36641478 |
| | Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease | Q37049901 |
| | Review of the SPARCL trial and its subanalyses | Q37509299 |
| | Statin use in spontaneous intracerebral hemorrhage: a systematic review and meta-analysis | Q38573689 |
| | Low serum cholesterol and the risk of cerebral haemorrhage | Q41224189 |
| | Statins Enhance Expression of Growth Factors and Activate the PI3K/Akt-mediated Signaling Pathway after Experimental Intracerebral Hemorrhage | Q41544765 |
| | Acute Statin Treatment Improves Recovery after Experimental Intracerebral Hemorrhage | Q42058571 |
| | Effect of statin use during hospitalization for intracerebral hemorrhage on mortality and discharge disposition | Q44111232 |
| | Association of statins and statin discontinuation with poor outcome and survival after intracerebral hemorrhage | Q44932878 |
| | Serum cholesterol LDL and 90-day mortality in patients with intracerebral hemorrhage | Q46082065 |
| | Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage | Q46772417 |
| | Statins improve outcome in murine models of intracranial hemorrhage and traumatic brain injury: a translational approach | Q48719204 |
| | Low Cholesterol as a Risk Factor for Primary Intracerebral Hemorrhage: A Case-Control Study | Q58478410 |
| | Spontaneous intracerebral hemorrhage | Q73862624 |
| | Low serum cholesterol as a risk factor for hemorrhagic stroke in men: a community-based mass screening in Okinawa, Japan | Q74618981 |
| | Serum low-density lipoprotein cholesterol level predicts hematoma growth and clinical outcome after acute intracerebral hemorrhage | Q84615575 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2098-2104 | |
| P577 | publication date | 2017-06-29 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Use of Statins and Outcomes in Intracerebral Hemorrhage Patients | |
| P478 | volume | 48 | |